Free Case Evaluation -
TThe Justice Coalition helps individuals nationwide who developed cancer after taking Zantac or ranitidine-containing medications. If you or a loved one has been diagnosed with cancer potentially linked to Zantac, you have a legal claim against the drug manufacturers.
In April 2020, the FDA issued a nationwide request for the removal of all Zantac (ranitidine) products from pharmacy shelves, including both prescription and over-the-counter versions. This decision came after testing revealed that many ranitidine-based drugs contained dangerous levels of NDMA (N-Nitrosodimethylamine) — a chemical classified as a probable human carcinogen.
Zantac was once one of the most commonly used medications for heartburn, acid reflux, and GERD (gastroesophageal reflux disease). However, concerns began in 2019 when researchers found that NDMA levels in ranitidine could increase over time, especially when exposed to heat, making the drug potentially unsafe for consumers.
NDMA is a highly toxic substance that has been linked to cancer in multiple organ systems. In laboratory testing, exposure to NDMA has caused cancer in animals and serious reproductive harm. Studies have shown that even low levels of long-term exposure may increase the risk of developing bladder cancer, stomach cancer, liver cancer, and other serious conditions.
The FDA has advised all consumers to stop using any remaining ranitidine products and to speak with their healthcare provider about safer alternatives.
Lawsuits have been filed against the makers of Zantac claiming the side effects and range of injuries from ingesting NDMA are significant. Taking Zantac has been linked to the following types of cancer:
We will never share your information. Privacy Policy.
